JW Therapeutics, a China-based clinical stage biopharmaceutical company, has raised $90 million in a Series A round of funding led by Temasek Holdings, Sequoia Capital China, and Yuan Ming Capital.
Other new investors include Oriza Seed Capital, Yipu Capital, and AVICT Holdings, while existing backers Juno Therapeutics and Wuxi AppTec have re-upped. JW Therapeutics is a joint venture established...
China Ping An Insurance Overseas Holdings has aspirations to manage assets for third-party investors. Spinning out part of the global private equity portfolio may help it get there
Buoyed by strong macro fundamentals and robust returns, Japan’s buyout managers continue to attract capital while most other strategies across Asia struggle. Will this popularity be sustained?
Zhenkunhang, a China-based distribution platform for industrial products, has raised $315 million Series E funding led by YF Capital - previously Yunfeng Capital - a private equity firm co-founded by Alibaba’s Jack Ma.
Japanese logistics technology start-up Openlogi has raised JPY1.7 billion ($16.7 million) in an ongoing Series C round featuring Sumitomo Corporation.